scholarly journals The Comparison of the Protective Effects of α- and β-Antithrombin against Vascular Endothelial Cell Damage Induced by Histone in Vitro

TH Open ◽  
2017 ◽  
Vol 01 (01) ◽  
pp. e3-e10 ◽  
Author(s):  
Toshiaki Iba ◽  
Tetsuya Sasaki ◽  
Kazutoshi Ohshima ◽  
Koichi Sato ◽  
Isao Nagaoka ◽  
...  

AbstractAntithrombin is a promising option for the treatment of sepsis, and vascular endothelium is an important target for this fatal condition. Here, we aimed to evaluate the protective effects of different glycoforms of antithrombin on histone-induced endothelial cell damage and explore the responsible mechanisms in an experimental model in vitro. Endothelial cells were treated in vitro using histone H4 to induce cellular damage. Various doses of either α- or β-antithrombin were used as treatment interventions, and both cell viability and the levels of lactate dehydrogenase (LDH) in the medium were assessed. Endothelial cell damage was also assessed using microscopic examination and immunofluorescent staining with anti-syndecan-4 and anti-antithrombin antibodies. As a result, both glycoforms of antithrombin significantly improved cell viability when administered at a physiological dose (150 μg/mL). Cellular injury as evaluated using the LDH level was significantly suppressed by β-antithrombin at a supranormal dose (600 μg/mL). Microscopic observation suggested that β-antithrombin suppressed the endothelial cell damage more efficiently than α-antithrombin. β-Antithrombin suppressed the intensity of syndecan-4 staining which became evident after treatment with histone H4, more prominently than α-antithrombin. The distribution of antithrombin was identical to that of syndecan-4. In conclusion, both α- and β-antithrombin can protect vascular endothelial cells from histone H4-induced damage, although the effect was stronger for β-antithrombin. The responsible mechanisms might involve the binding of antithrombin to the glycocalyx on the endothelial surface. These results provide a theoretical basis for the application of antithrombin to the prevention and treatment of sepsis-related endothelial damage.

2009 ◽  
Vol 30 (3) ◽  
pp. 545-554 ◽  
Author(s):  
Jiabin Guo ◽  
Diana N Krause ◽  
James Horne ◽  
John H Weiss ◽  
Xuejun Li ◽  
...  

Protective effects of estrogen against experimental stroke and neuronal ischemic insult are well-documented, but it is not known whether estrogen prevents ischemic injury to brain endothelium, a key component of the neurovascular unit. Increasing evidence indicates that estrogen exerts protective effects through mitochondrial mechanisms. We previously found 17β-estradiol (E2) to improve mitochondrial efficiency and reduce mitochondrial superoxide in brain blood vessels and endothelial cells. Thus we hypothesized E2 will preserve mitochondrial function and protect brain endothelial cells against ischemic damage. To test this, an in vitro ischemic model, oxygen-glucose deprivation (OGD)/reperfusion, was applied to immortalized mouse brain endothelial cells (bEnd.3). OGD/reperfusion-induced cell death was prevented by long-term (24, 48 h), but not short-term (0.5, 12 h), pretreatment with 10 nmol/L E2. Protective effects of E2 on endothelial cell viability were mimicked by an estrogen-receptor (ER) agonist selective for ERα (PPT), but not by one selective for ERβ (DPN). In addition, E2 significantly decreased mitochondrial superoxide and preserved mitochondrial membrane potential and ATP levels in early stages of OGD/reperfusion. All of the E2 effects were blocked by the ER antagonist, ICI-182,780. These findings indicate that E2 can preserve endothelial mitochondrial function and provide protection against ischemic injury through ER-mediated mechanisms.


2004 ◽  
Vol 72 (1) ◽  
pp. 598-601 ◽  
Author(s):  
Angela A. Sanchez ◽  
Douglas A. Johnston ◽  
Carter Myers ◽  
John E. Edwards ◽  
Aaron P. Mitchell ◽  
...  

ABSTRACT Candida albicans must penetrate the endothelial cell lining of the vasculature to invade the deep tissues during a hematogenously disseminated infection. We compared 27 C. albicans mutants with their wild-type parent for their capacity to damage endothelial cells in vitro and cause a lethal infection in mice following tail vein inoculation. Of 10 mutants with significantly impaired capacity to damage endothelial cells, all had attenuated virulence. Therefore, the endothelial cell damage assay can be used as a screen to identify some virulence factors relevant to hematogenously disseminated candidiasis.


1999 ◽  
Vol 27 (03n04) ◽  
pp. 331-338 ◽  
Author(s):  
Chun-Su Yuan ◽  
Anoja S. Attele ◽  
Ji An Wu ◽  
Tasha K. Lowell ◽  
Zhenlun Gu ◽  
...  

Endothelial cell damage is considered to be the initial step in the genesis of thrombosis and arteriosclerosis, the common precursors of cardiovascular disorders. In this study, we evaluated the protective effects of American ginseng or Panax quinquefolium L. extracts on endothelial cell injury, and investigated effects of ginseng extracts on thrombin-induced endothelin release using cultured human umbilical vein endothelial cells. We observed that when endothelial cells pretreated with 1, 10, and 100 μg/ml of Panax quinquefolium L. extracts were incubated for 4 and 24 hr with thrombin, the concentration of endothelin was significantly decreased in a concentration dependent, time related manner (at 4 hr, IC50 = 5.1 μg/ml; at 24 hr, IC50 = 6.2 μg/ml). We further evaluated the effects of NG-nitro-L-arginine (NLA), a nitric oxide (NO) synthetase inhibitor, on the activity of Panax quinquefolium L. extracts. Following pretreatment of cultured endothelial cells with NLA, the inhibition of thrombin-induced endothelin release by Panax quinquefolium L. was significantly reduced (P < 0.05). This result suggests that the pharmacological action of Panax quinquefolium L. is, at least partially, due to NO release. Our data demonstrate that American ginseng may play a therapeutic role in facilitating the hemodynamic balance of vascular endothelial cells.


2014 ◽  
Vol 912-914 ◽  
pp. 1965-1968
Author(s):  
Wen He Zhu ◽  
Wei Zhang ◽  
Ying Xin Qin ◽  
Nan Shen ◽  
Li Jing Zhao ◽  
...  

Abstract: Objective: To investigate whether the extract of Juglans mandshurica maxim could inhibits the apoptosis induced by endogenous H2O2 on Endothelial Cell (EVC-304)in vitro. METHODS: Cultured EVC-304 cells were incubated with 10mUGOX or with 10mUGOX and different concentrations (25μg/ mL, 50μg/ mL, 100μg/ mL) of the extract of Juglans mandshurica maxim for 24h.The proliferation of EVC-304cells was detected by methyl thiazolyl tetrazolium (MTT) assay. The early apoptotic percent was measured by flow cytometry (FCM). RESULTS: MTT results showed that the inhibition proliferation of EVC-304 cells induced by endogenous H2O2 could be inhibited by the extract of Juglans mandshurica maxim in a dose -dependent manner. FCM assay indicated that, after treatment on EVC-304 cells with endogenous H2O2, the early apoptotic percent was increased, but the apoptosis rate was decreased significantly when the extract of Juglans mandshurica maxim added. CONCLUSION: the extract of Juglans mandshurica maxim protected significantly the cell damage and cell apoptosis induced by endogenous H2O2.


1990 ◽  
Vol 85 (2-3) ◽  
pp. 161-167 ◽  
Author(s):  
Nobuhiko Tanimura ◽  
Yujiro Asada ◽  
Tohru Hayashi ◽  
Atsushi Kisanuki ◽  
Akinobu Sumiyoshi

Blood ◽  
2010 ◽  
Vol 115 (20) ◽  
pp. 4130-4137 ◽  
Author(s):  
Jinmin Gao ◽  
Lei Sun ◽  
Lihong Huo ◽  
Min Liu ◽  
Dengwen Li ◽  
...  

Cylindromatosis (CYLD) is a deubiquitinase that was initially identified as a tumor suppressor and has recently been implicated in diverse normal physiologic processes. In this study, we have investigated the involvement of CYLD in angiogenesis, the formation of new blood vessels from preexisting ones. We find that knockdown of CYLD expression significantly impairs angiogenesis in vitro in both matrigel-based tube formation assay and collagen-based 3-dimensional capillary sprouting assay. Disruption of CYLD also remarkably inhibits angiogenic response in vivo, as evidenced by diminished blood vessel growth into the angioreactors implanted in mice. Mechanistic studies show that CYLD regulates angiogenesis by mediating the spreading and migration of vascular endothelial cells. Silencing of CYLD dramatically decreases microtubule dynamics in endothelial cells and inhibits endothelial cell migration by blocking the polarization process. Furthermore, we identify Rac1 activation as an important factor contributing to the action of CYLD in regulating endothelial cell migration and angiogenesis. Our findings thus uncover a previously unrecognized role for CYLD in the angiogenic process and provide a novel mechanism for Rac1 activation during endothelial cell migration and angiogenesis.


Blood ◽  
2017 ◽  
Vol 130 (Suppl_1) ◽  
pp. 992-992
Author(s):  
Chanchal Sur Chowdhury ◽  
Elizabeth Wareham ◽  
Juying Xu ◽  
Sachin Kumar ◽  
Ashwini S. Hinge ◽  
...  

Abstract Neutrophils traffic in and out of underlying vascular bed during hematopoiesis and immunosurveillance. However, during inflammatory conditions such as ischemia reperfusion injury or atherosclerosis, excessive neutrophil infiltration into tissue drives disease pathogenesis. Yet, the relationship between neutrophil transmigration and inflammation is ill-defined. Neutrophil extravasation can occur either between two endothelial cells (paracellular) or directly through an endothelial cell body (transcellular). During transcellular migration, neutrophils interact with underlying endothelial cells (EC) via invadosomal structures, which forms a 'pore' into endothelial cell membrane, thus facilitating neutrophil migration through EC body. We have recently reported that deficiency in Rap1b, a member of Ras superfamily of GTPase, enhanced neutrophil transcellular migration, invadosomal structures and metalloproteinase (MMP) release (Kumar et al, JEM, 2014), in a manner dependent on high Akt activity. Further, Rap1-deficiency increased neutrophil recruitment to inflamed lungs and enhanced susceptibility to endotoxin shock, suggesting mode of neutrophil migration may influence inflammatory outcome. Here, to further understand which factors drive neutrophil transcellular migration, we analyzed protein content of Rap1b-/- invadosomal structures during transcellular diapedesis. For this, neutrophils were stimulated in transwell filters of 1µM pore size, with FMLP placed in the lower chamber, allowing only invadosomal protrusions into the pores. After removing the cell body from top of the filter, mass spectrometric analysis was performed on the invadosomal fraction. About 680 proteins were identified in protrusions isolated from WT or Rap1b-/- neutrophils. As expected, majority of them were cytoskeleton and adhesion proteins. Interestingly, Rap1b-/- invadosomal structures contained more enzymes of glycolytic pathways, including HK1, Lactate dehydrogenase A (LDHA) and phosphoglycerate kinase1 (PGK1). Immunofluorescent staining and western blotting confirmed this observation. Importantly, glycolytic enzymes were present at the tip of the protrusions in colocalization with F-actin suggesting site specific glycolytic activity, raising the hypothesis that metabolic remodeling may influence the route of neutrophil migration. LDHA converts pyruvate to lactate and subsequent milieu acidification, which can then cause MMP activation. Consistently, Rap1b-/- neutrophils exhibited increased uptake of glucose analogue (2-NBDG) and concurrent intracellular acidification, as detected by pH sensitive dye. To investigate the importance of LDHA activity during transcellular migration, Rap1b-/- neutrophils were treated with a specific pharmacological inhibitor of LDHA, namely FX11. In vitro, FX11 treatment significantly decreased transcellular migration of Rap1b-/- neutrophils. It also reduced invadosome formation of Rap1b-/- neutrophils within transwell pores, as well as neutrophil acidity and MMP activity. Furthermore, during neutrophil-endothelial cell interactions in vitro, Rap1b-/- neutrophils caused F-actin depolymerization in EC, likely facilitating transcellular passage; this was inhibited by FX11. To examine its effect in vivo, under same inflammatory microenvironment, Rap1b-/- and WT neutrophils were tagged with cell tracker dyes and transferred to recipient mice, treated with FX11 or DMSO control. Ear microvasculature was stimulated with FMLP and labeled with PECAM antibody to visualize EC junctions. Rap1b-/- neutrophils migrated out of vessels at higher frequency than WT cells, which was abrogated by FX11 treatment. Moreover, treatment with FX11 reduced the number of Rap1b-/- neutrophils located away from EC junction (transcellular route), in vivo. These results suggest enhanced local glycolytic metabolism and LDHA activity could act as critical regulators of transcellular migration. Increase in extracellular acidification mediated by LDHA activity, could affect endothelial permeability and alter neutrophil migratory behavior affecting outcome of inflammation. Since milieu acidification plays a major role in ischemic damage to the heart, these findings may be clinically important for our understanding of hyperinflammatory disorders. Disclosures No relevant conflicts of interest to declare.


2021 ◽  
Author(s):  
Yutaro Madokoro ◽  
Chinatsu Kamikokuryo ◽  
Shuhei Niiyama ◽  
Takashi Ito ◽  
Satoshi Hara ◽  
...  

Abstract Ascorbic acid (AsA) therapy for sepsis is thought to have a protective effect on vascular endothelial cells, but the effect of AsA therapy on endothelial cell dysfunction over time and the appropriate timing for AsA administration to demonstrate efficacy is unclear. Septic mice, induced by cecal ligation and puncture (CLP), were examined for the effect of AsA administration (200 mg/kg) on vascular endothelial cell dysfunction at two administration timings: early group (AsA was administered immediately after CLP) and late group (AsA was administered 12 h after CLP). Survival rates were compared between the early and late administration groups, and vascular endothelial cell damage, indicated by the dihydrobiopterin/tetrahydrobiopterin ratio, serum syndecan-1, and endothelial nitric oxide synthase, as well as liver damage, were examined. The early group showed significantly improved survival compared to the non-treatment group (p < 0.05), while the late group showed no improved survival compared to the non-treatment group. Early AsA administration suppressed damage to the vascular endothelial system and liver compared to the non-treatment group. In septic mice, early AsA administration immediately after CLP may have protective effects on vascular endothelial cells, resulting in reduced organ dysfunction and improved survival.


Sign in / Sign up

Export Citation Format

Share Document